ImmuCell CorporationICCCNASDAQ

Revenue (LTM)

$28M

+4.3% YoY

Net Income (LTM)

$-1M

+51.8% YoY

Free Cash Flow

Revenue CAGR (5Y)

+9.5%

Marginsdeclining

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	19	19↓3.5%	17↓5.9%	26↑51.6%	28↑4.3%
Gross Profit	9	8↓11.6%	4↓42.5%	8↑80.6%	11↑44.1%
Operating Income	0	-2↓993.2%	-6↓150.0%	-2↑71.5%	2↑200.5%
Net Income	-0	-2↓3085.5%	-6↓131.5%	-2↑62.7%	-1↑51.8%
EBITDA	3	0↓87.0%	-3↓815.5%	1↑142.6%	4↑315.6%
EPS Diluted	-0.01	-0.32↓3006.8%	-0.75↓134.4%	-0.26↑65.3%	-0.12↑53.8%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	10	6↓43.1%	1↓83.1%	4↑284.0%	4↑1.3%
Total Current Assets	16	14↓14.0%	11↓18.0%	15↑31.2%	13↓13.1%
Total Assets	44	45↑0.9%	44↓2.3%	45↑3.0%	43↓5.7%
Total Current Liabilities	3	3↑21.2%	4↑36.6%	4↑5.1%	0
Total Liabilities	12	14↑21.8%	19↑29.9%	18↓6.6%	0
Total Equity	33	30↓6.7%	25↓17.7%	28↑10.1%	0
Total Debt	10	12↑21.5%	17↑33.7%	15↓9.5%	0
Net Debt	0	7↑7411.8%	16↑134.9%	11↓27.8%	-4↓133.6%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	1	-2↓261.8%	-5↓202.8%	0↑107.7%	0
Capital Expenditure	-3	-4↓52.4%	-2↑52.4%	-0↑75.4%	0
Free Cash Flow	-2	-6↓233.6%	-7↓19.0%	-0↑98.4%	0
Stock-Based Comp	0	0↑84.5%	0↑38.5%	0↓11.6%	0
Net Change in Cash	3	-4↓235.8%	-5↓9.5%	3↑157.8%	0↓98.2%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance